202 related articles for article (PubMed ID: 35472129)
1. ETS transcription factor ELF3 (ESE-1) is a cell cycle regulator in benign and malignant prostate.
Archer LK; Frame FM; Walker HF; Droop AP; McDonald GLK; Kucko S; Berney DM; Mann VM; Simms MS; Maitland NJ
FEBS Open Bio; 2022 Jul; 12(7):1365-1387. PubMed ID: 35472129
[TBL] [Abstract][Full Text] [Related]
2. ETS transcription factor ESE1/ELF3 orchestrates a positive feedback loop that constitutively activates NF-κB and drives prostate cancer progression.
Longoni N; Sarti M; Albino D; Civenni G; Malek A; Ortelli E; Pinton S; Mello-Grand M; Ostano P; D'Ambrosio G; Sessa F; Garcia-Escudero R; Thalmann GN; Chiorino G; Catapano CV; Carbone GM
Cancer Res; 2013 Jul; 73(14):4533-47. PubMed ID: 23687337
[TBL] [Abstract][Full Text] [Related]
3. E74 like ETS transcription factor 3 (ELF3) is a negative regulator of epithelial- mesenchymal transition in bladder carcinoma.
Gondkar K; Patel K; Krishnappa S; Patil A; Nair B; Sundaram GM; Zea TT; Kumar P
Cancer Biomark; 2019; 25(2):223-232. PubMed ID: 31104013
[TBL] [Abstract][Full Text] [Related]
4. E26 transformation (ETS)‑specific related transcription factor‑3 (ELF3) orchestrates a positive feedback loop that constitutively activates the MAPK/Erk pathway to drive thyroid cancer.
Chen H; Chen W; Zhang X; Hu L; Tang G; Kong J; Wang Z
Oncol Rep; 2019 Jan; 41(1):570-578. PubMed ID: 30365150
[TBL] [Abstract][Full Text] [Related]
5. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
[TBL] [Abstract][Full Text] [Related]
6. ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer.
Luk IY; Reehorst CM; Mariadason JM
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200227
[TBL] [Abstract][Full Text] [Related]
7. A transcriptional repressive role for epithelial-specific ETS factor ELF3 on oestrogen receptor alpha in breast cancer cells.
Gajulapalli VN; Samanthapudi VS; Pulaganti M; Khumukcham SS; Malisetty VL; Guruprasad L; Chitta SK; Manavathi B
Biochem J; 2016 Apr; 473(8):1047-61. PubMed ID: 26920025
[TBL] [Abstract][Full Text] [Related]
8. ELF3 is a negative regulator of epithelial-mesenchymal transition in ovarian cancer cells.
Yeung TL; Leung CS; Wong KK; Gutierrez-Hartmann A; Kwong J; Gershenson DM; Mok SC
Oncotarget; 2017 Mar; 8(10):16951-16963. PubMed ID: 28199976
[TBL] [Abstract][Full Text] [Related]
9. E74-Like Factor 3 Is a Key Regulator of Epithelial Integrity and Immune Response Genes in Biliary Tract Cancer.
Suzuki M; Saito-Adachi M; Arai Y; Fujiwara Y; Takai E; Shibata S; Seki M; Rokutan H; Maeda D; Horie M; Suzuki Y; Shibata T; Kiyono T; Yachida S
Cancer Res; 2021 Jan; 81(2):489-500. PubMed ID: 33293429
[TBL] [Abstract][Full Text] [Related]
10. ELF3 promotes epithelial-mesenchymal transition by protecting ZEB1 from miR-141-3p-mediated silencing in hepatocellular carcinoma.
Zheng L; Xu M; Xu J; Wu K; Fang Q; Liang Y; Zhou S; Cen D; Ji L; Han W; Cai X
Cell Death Dis; 2018 Mar; 9(3):387. PubMed ID: 29523781
[TBL] [Abstract][Full Text] [Related]
11. The function of the ELF3 gene and its mechanism in cancers.
Ju Y; Fang S; Liu L; Ma H; Zheng L
Life Sci; 2024 Jun; 346():122637. PubMed ID: 38614305
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer.
Wang H; Yu Z; Huo S; Chen Z; Ou Z; Mai J; Ding S; Zhang J
Int J Biochem Cell Biol; 2018 Jan; 94():98-106. PubMed ID: 29208568
[TBL] [Abstract][Full Text] [Related]
13. Genomic organization of the human ELF3 (ESE-1/ESX) gene, a member of the Ets transcription factor family, and identification of a functional promoter.
Oettgen P; Barcinski M; Boltax J; Stolt P; Akbarali Y; Libermann TA
Genomics; 1999 Feb; 55(3):358-62. PubMed ID: 10049594
[TBL] [Abstract][Full Text] [Related]
14. ELF3 is a repressor of androgen receptor action in prostate cancer cells.
Shatnawi A; Norris JD; Chaveroux C; Jasper JS; Sherk AB; McDonnell DP; Giguère V
Oncogene; 2014 Feb; 33(7):862-71. PubMed ID: 23435425
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-specific ETS-1 (ESE1/ELF3) regulates apoptosis of intestinal epithelial cells in ulcerative colitis via accelerating NF-κB activation.
Li L; Miao X; Ni R; Miao X; Wang L; Gu X; Yan L; Tang Q; Zhang D
Immunol Res; 2015 Jun; 62(2):198-212. PubMed ID: 25926267
[TBL] [Abstract][Full Text] [Related]
16. LncRNA ELF3-AS1 Promotes Non-Small Cell Lung Cancer Cell Invasion and Migration by Downregulating miR-212.
Zhang Z; Nong L; Chen ML; Gu XL; Zhao WW; Liu MH; Cheng WW
Cancer Biother Radiopharm; 2022 Mar; 37(2):119-124. PubMed ID: 32598181
[TBL] [Abstract][Full Text] [Related]
17. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
AbdulMajeed AA; Dalley AJ; Farah CS
Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
[TBL] [Abstract][Full Text] [Related]
18. Identification of the gene expression changes and gene regulatory aspects in ELF3 mutant bladder cancer.
Guneri-Sozeri PY; Erkek-Ozhan S
Mol Biol Rep; 2022 Apr; 49(4):3135-3147. PubMed ID: 35199247
[TBL] [Abstract][Full Text] [Related]
19. A novel regulatory relationship between RIPK4 and ELF3 in keratinocytes.
Scholz GM; Sulaiman NS; Al Baiiaty S; Kwa MQ; Reynolds EC
Cell Signal; 2016 Dec; 28(12):1916-1922. PubMed ID: 27667567
[TBL] [Abstract][Full Text] [Related]
20. CircHIPK3 promotes proliferation and invasion in nasopharyngeal carcinoma by abrogating miR-4288-induced ELF3 inhibition.
Ke Z; Xie F; Zheng C; Chen D
J Cell Physiol; 2019 Feb; 234(2):1699-1706. PubMed ID: 30070690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
